Comparative evaluation of the effectiveness of a peptide-containing drug and polyoxydonium in the treatment of chronic parodontitis

Currently, the available methods of treating parodontitis are not able to have a complex effect. Therefore, in recent years, there has been an active search and development of new methods of treatment and new drugs that have a complex etiopathogenetic effect on this disease.
This article provides a comparative evaluation of the classical and experimental methods of treating chronic periodontitis. Based on the reconstruction of an experimental model of chronic inflammation of periodontal tissues of the Wistar rat line, we compared methods of topical therapy by “Organosilicon Glycerohydrogel – Peptide” and “Polyoxidonium” compositions. A comparative assessment of the activity of these drugs with control groups, which were treated with “Organosilicon Glycerohydrogel” and “Metrogyl Denta”, was carried out.
Previously, we carried out separate studies of the effectiveness of the use of the composition “organosilicon glycerohydrogel – peptide”, as well as the method of treatment of periodontitis, by injecting the drug “Polyoxidonium”. They have been compared with the classic treatment for this disease to obtain relevant data and results.
In our opinion, the data obtained are of considerable interest. The assessment and comparison of clinical and histological data have been carried out, which showed that all drugs had a positive effect on the processes of tissue regeneration. However, the composition “Organosilicon Glycerohydrogel-peptide”, due to the characteristics of the hydrogel, which is acting as a transcutaneous conductor, showed a faster antimicrobial and pathogenetic effect, which allows a comprehensive approach to solving this problem. In comparison with the groups of “Organosilicon Glycerohydrogel” and “Polyoxidonium”, the period of clinical improvement increased by 57% in the group of “Glycerohydrogel-Peptide”, and, in the “Metrogyl Denta” group, the indicators improved by 15% approximately.

1. Andriasyan L.H. Immunological concept of tooth-periodontal inter- relations in norm and pathology. New Armenian Medical Journal, 2014, Vol. 8, no. 3, pp. 27-36.

2. Brinkac L., Voorhies A., Gomez A., Nelson K.E. The threat of antimicrobial resistance on the human microbiome. Microb. Ecol., 2017, Vol. 74, no. 4, pp. 1001-1008.

3. Carmona-Ribeiro A.M., de Melo Carrasco L.D. Novel formulations for antimicrobial peptides. Int. J. Mol. Sci., 2014, Vol. 15, no. 10, 18040-83. doi: 10.3390/ijms151018040.

4. Chupakhin O.N., Simbirtsev A.S., Tuzankina I.A., Honina T.G., Tosova I.N., Larionov L.P., Ron’ G.I., Sarkisyan N.G., Chernysheva N.D. The patent for the invention No. 2470640 of the Russian Federation. Means for treating inflammatory diseases of the oral cavity and a method of treating inflammatory diseases of the oral cavity. publ. 12/27/2012. Bull. 2012. No. 36. 16 p.

5. Levine M., LaPolla S., Owen W.L., Socransky S.S. Antibody-based diagnostic for ‘refractory’ periodontitis. J. Clin. Periodontol., 2002, Vol. 29, no. 10, pp. 935-943.

6. Musin H.G. Antimicrobial peptides are potentially noticeable to traditional antibiotics. Infection and immunity, 2018, Vol. 8, no. 3, pp. 295-308. (In Russ.) doi: 10.15789/2220-7619-2018-3-295-308.

7. Natsvlishvili T.T., Tsimbalistov A.V., Shtorina G.B., Kadurina T.I. Clinical and radiological parallels of generalized forms of aggressive and chronic periodontitis. Herald of North-Western State Medical University named after I.I. Mechnikov, 2011, Vol. 3, no. 4, pp. 97-100. (In Russ.)

8. Ovsyepyan N.A., Tuzankina I.A., Sarkisyan N.G., Dolgih M.A., Sokolova K.V. Use of the topical therapeutic composition, containing drug Acegram and silativit gel, on the model of chronic parodontitis in rats. Russian Journal of Immunonology, 2017, Vol. 11, no. 3, pp. 448-450. (In Russ.)

9. Sarkisyan N.G., Chumakov N.S., Grenaderova M.A. Experimental evaluation of the efficiency of the peptide-containing drug in the treatment of chronic periodontitis. Russian Journal of Immunonology, 2019, Vol. 22, no. 3, pp. 1258-1262. (In Russ.)

10. Sarkisyan N.G., Drozdova L.I., Umarova D.S., Solovyova D.A., Khlystova K.A. Assessed efficacy of polyoxidonium in medicated treatment of modelled chronic periodontitis (experimental study). Russian Journal of Immunology, 2020, vol. 23, no. 1, pp. 91-96. (In Russ.)

11. Sarkisyan N.G., Ron G.I., Tuzankina I.A., Honina T.G., Larionov L.P., Simbirtsev A.S., Drozdova L.I., Timchenko A.S. Morphological assessment of the effectiveness of the use of pharmacological compositions based on organosilicon glycerohydrogel. Immunologiya, 2017, Vol. 38, no. 2, pp. 91-96. (In Russ.)

12. Sarkisyan N.G., Timchenko A.S., Larionov L.P., Tuzankina I.A. A method of obtaining a model of chronic periodontitis in rats. Ural Medical Journal, 2014, no. 3. pp. 54-56. (In Russ.)

13. Sztukowska M.N., Roky M, Demuth D.R. Peptide and non-peptide mimetics as potential therapeutics targeting oral bacteria and oral biofilms. Mol. Oral Microbiol., 2019, no. 34, pp. 169-182.

14. Usova N.F. Inflammatory periodontal diseases: pathogenesis, principles of complex treatment. Siberian Medical Journal, 2013, Vol. 116, no. 1, pp. 141-144. (In Russ.)